Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer.
about
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerMonte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PETRecurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study.Pre-therapeutic (124)I PET(/CT) dosimetry confirms low average absorbed doses per administered (131)I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer.Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.Is the image quality of I-124-PET impaired by an automatic correction of prompt gammas?The future of hybrid imaging-part 2: PET/CT.Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for localizing recurrence in patients with differentiated thyroid carcinomaEstimating (131)I biokinetics and radiation doses to the red marrow and whole body in thyroid cancer patients: probe detection versus image quantification.I-124 Imaging and Dosimetry.Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems.Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer.Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer.Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of precPrognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.Calibration of PET/CT scanners for multicenter studies on differentiated thyroid cancer with (124)I.Dosimetric effectiveness of targeted radionuclide therapy based on a pharmacokinetic landscape.¹²⁴I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy ¹³¹I SPECT/CT.Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy.Diagnosis and dosimetry in differentiated thyroid carcinoma using 124I PET: comparison of PET/MRI vs PET/CT of the neck.Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy.Evaluation of (124)I PET/CT and (124)I PET/MRI in the management of patients with differentiated thyroid cancer.Imaging with (124)I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT?
P2860
Q30367068-7EDC014B-7139-4DA0-A2E2-0CAFDD087EE4Q33682852-EBEC8F15-3CE9-4F27-BF29-B79A01E75497Q33759426-2F428BDD-051D-4CBF-BA01-59E2DB969917Q33790290-7424EC08-F2F6-44FF-AA81-39B72D47F765Q34117552-1332961A-4B8F-4B1E-8212-880783F1C45EQ34981083-66A5E5AB-C7C6-45DD-ADCD-AA00ACC99FB5Q35786046-ADB8738C-123F-42A3-9A4A-6A0A3155A5A9Q36195634-F403F4F0-D890-413B-A695-0DCDE192A6B7Q37079244-3341CFD6-A3DB-4F8C-AE5D-82FC02C9D7D3Q37616594-1DB3E48A-7044-45AD-952A-C97C2641C33FQ37633048-4A51C5DD-C152-4DC0-B863-CF533D5F13EEQ37639910-1DA57059-456B-4386-800F-2C123352582FQ37864158-6C099255-3CFD-4A69-AAF7-DAD45BC7C66CQ39313472-E0ACE43D-95D6-40AA-A765-C6C7D6BBBE18Q39819035-BDB91FB4-7FB5-4134-8AF2-A57C8052D3FDQ40729504-E1EF71CC-3988-4118-8345-A3E390EE60C0Q42961805-111B9706-1B46-47B7-B777-29FCDDD771E6Q44597379-7AF4C6C2-CF76-4B8E-92CF-33ACF76095CEQ46073511-B3D472B4-DD8F-43A3-BE49-164F882DF9C1Q46332947-8022E743-7088-478E-91C2-B742234EFED9Q50536307-857B6515-5DA0-4D48-AF10-151BBD6226F0Q52984601-DEDE1046-CBD5-4A9A-A4A5-9C98AEAFD3A6Q52986508-94AEC654-6808-412E-A736-68DE0BEE7C4C
P2860
Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Optimized 124I PET dosimetry p ...... differentiated thyroid cancer.
@en
Optimized 124I PET dosimetry p ...... differentiated thyroid cancer.
@nl
type
label
Optimized 124I PET dosimetry p ...... differentiated thyroid cancer.
@en
Optimized 124I PET dosimetry p ...... differentiated thyroid cancer.
@nl
prefLabel
Optimized 124I PET dosimetry p ...... differentiated thyroid cancer.
@en
Optimized 124I PET dosimetry p ...... differentiated thyroid cancer.
@nl
P2093
P1476
Optimized 124I PET dosimetry p ...... differentiated thyroid cancer.
@en
P2093
Ernst G Eising
Jochen Knust
Lutz Freudenberg
Walter Jentzen
Wilfried Sonnenschein
P304
P356
10.2967/JNUMED.107.047159
P407
P577
2008-05-15T00:00:00Z